Home
About
Overview
Sharing Data
ORCID
Help
History (104)
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies.
Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors.
ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
miRNAs in lung cancer: large roles for small players.
See All 104 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
miRNAs in lung cancer: large roles for small players.
Cherni I, Weiss GJ. miRNAs in lung cancer: large roles for small players. Future Oncol. 2011 Sep; 7(9):1045-55.
View in:
PubMed
subject areas
Biomarkers, Tumor
Cell Transformation, Neoplastic
Drug Resistance, Neoplasm
Early Detection of Cancer
Gene Expression Profiling
Humans
Lung Neoplasms
MicroRNAs
Neoplasm Metastasis
Prognosis
Radiation Tolerance
authors with profiles
Glen Weiss MD, MBA